Results 251 to 260 of about 928,903 (364)

Triple transcatheter and surgical valve replacement: a ‘hybrid’ approach to valvular heart disease [PDF]

, 2015
Alexander Lauten, Torsten Doenst, Hans R. Figulla   +2 more
openalex   +1 more source

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

ESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher, Roger Hodkinson, William Makis, Peter A. McCullough   +3 more
wiley   +1 more source

Congenital Heart Disease from Infancy to Adulthood: Pathology and Nosology. [PDF]

Biomedicines
Thiene G, Fedrigo M.
europepmc   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Beyond the Timeline: 1-Year Mortality Trends in Early Versus Late Prosthetic Valve Endocarditis. [PDF]

Clin Infect Dis
Papadimitriou-Olivgeris M, Ledergerber B, Siedentop B, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M, Epprecht J, van Hemelrijck M, Dzemali O, Guery B, Hasse B.   +12 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Feasibility and reproducibility of tissue motion annular displacement of mitral valve in children with and without heart disease

, 2013
Virginie Chelini, Sébastien Hascoët, K. Hadeed, O. Weil, Marianne Peyre, Y. Dulac, P. Acar   +6 more
openalex   +1 more source

Comparison of Outcomes of Percutaneous Mechanical Aspiration vs Tricuspid Valve Surgery in Drug Use-Associated Endocarditis of the Tricuspid Valve. [PDF]

Open Forum Infect Dis
Purcell M, Gnilopyat S, Makwana B, Narayanan S.   +3 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Managing Cardiogenic Shock With Concurrent Transcatheter Aortic Valve Replacement and Percutaneous Coronary Intervention. [PDF]

JACC Case Rep
Tan T, Zhu E, Cui H, Lai Y.
europepmc   +1 more source